Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012

European Journal of Cancer

Volumn 48, Issue 18, 2012, Pages 3439-3447

  Preusser, Matthias ^a   Winkler, Frank ^b   Collette, Laurence ^c   Haller, Sven ^d   Marreaud, Sandrine ^c   Soffietti, Riccardo ^e   Klein, Martin ^f   Reijneveld, Jaap C ^f   Tonn, Jörg Christian ^g   Baumert, Brigitta G ^h   Mulvenna, Paula ⁱ   Schadendorf, Dirk ^j   Duchnowska, Renata ^k   Berghoff, Anna Sophie ^a,l   Lin, Nancy ^m   Cameron, David A ⁿ   Belkacemi, Yazid ^o,p,q   Jassem, Jacek ^r   Weber, Damien C ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c EORTC DATA CENTER   (Belgium)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e MOLINETTE HOSPITAL   (Italy)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF MUNICH   (Germany)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ FREEMAN HOSPITAL   (United Kingdom)

^j UNIVERSITY HOSPITAL ESSEN   (Germany)

^k MILITARY INSTITUTE OF MEDICINE   (Poland)

^l MEDICAL UNIVERSITY OF VIENNA   (Austria)

^m D Farber Cancer Institute   (United States)

ⁿ WESTERN GENERAL HOSPITAL   (United Kingdom)

^o HENRI MONDOR HOSPITAL   (France)

^p UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^q AROME (Association of Radiotherapy and Oncology of the Mediterranean Area)   (France)

^r MEDICAL UNIVERSITY OF GDANSK   (Poland)

more..

Author keywords

Brain metastases; Clinical trail; EORTC; Prophylaxis

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; ERLOTINIB; GADOLINIUM; GEFITINIB; IPILIMUMAB;

BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL PROTOCOL; COGNITION; COGNITIVE DEFECT; FLUID ATTENUATED INVERSION RECOVERY IMAGING; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL SOCIETY; METHODOLOGY; MORBIDITY; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PATIENT MONITORING; PATIENT SAFETY; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; STUDY DESIGN; SUSCEPTIBILITY WEIGHTED IMAGING; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84869504594     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.07.002     Document Type: Article

References (56)

1. M.P. Mehta, M.N. Tsao, and T.J. Whelan The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases Int J Radiat Oncol Biol Phys 63 1 2005 37 46 (Pubitemid 41583540)
2. S. Villa, D.C. Weber, and C. Moretones Validation of the new Graded Prognostic Assessment scale for brain metastases: A multicenter prospective study Radiat Oncol 6 2011 23
3. M.H. Amer, M. Al-Sarraf, L.H. Baker, and V.K. Vaitkevicius Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival Cancer 42 2 1978 660 668 (Pubitemid 8405861)
4. D.E. Weissman Glucocorticoid treatment for brain metastases and epidural spinal cord compression: A review J Clin Oncol 6 3 1988 543 551 (Pubitemid 18090704)
5. L.E. Gaspar, M.P. Mehta, and R.A. Patchell The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline J Neurooncol 96 1 2010 17 32
6. S.N. Kalkanis, D. Kondziolka, and L.E. Gaspar The role of surgical resection in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline J Neurooncol 96 1 2010 33 43
7. M.E. Linskey, D.W. Andrews, and A.L. Asher The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline J Neurooncol 96 1 2010 45 68
8. M.P. Mehta, N.A. Paleologos, and T. Mikkelsen The role of chemotherapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline J Neurooncol 96 1 2010 71 83
9. D. Khuntia, P. Brown, J. Li, and M.P. Mehta Whole-brain radiotherapy in the management of brain metastasis J Clin Oncol 24 8 2006 1295 1304 (Pubitemid 46622033)
10. D.C. Weber, F. Caparrotti, M. Laouiti, and K. Malek Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: A prospective study on quality-of-life Radiat Oncol 6 2011 79
11. W.F. Regine, F.A. Schmitt, and C.B. Scott Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018 Int J Radiat Oncol Biol Phys 58 5 2004 1346 1352 (Pubitemid 38438293)
12. D. Steinmann, C. Schafer, and B. van Oorschot Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party Strahlenther Onkol 185 3 2009 190 197
13. G. Mitera, L. Zhang, and A. Sahgal A survey of expectations and understanding of palliative radiotherapy from patients with advanced cancer Clin Oncol (R Coll Radiol) 24 2 2012 134 138
14. E. Barnes, E. Chow, and M. Tsao Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy Int J Radiat Oncol Biol Phys 76 1 2010 187 192
15. V. Gondi, R. Tolakanahalli, and M.P. Mehta Hippocampal-sparing whole-brain radiotherapy: A "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 78 4 2010 1244 1252
16. A.N. Gutierrez, D.C. Westerly, and W.A. Tome Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: A planning study Int J Radiat Oncol Biol Phys 69 2 2007 589 597 (Pubitemid 47380106)
17. F. Hsu, H. Carolan, and A. Nichol Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: A feasibility study using volumetric modulated arc therapy Int J Radiat Oncol Biol Phys 76 5 2010 1480 1485
18. P.W. Sperduto, N. Kased, and D. Roberge Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases J Clin Oncol 30 4 2012 419 425
19. M. Preusser, D. Capper, and A. Ilhan-Mutlu Brain metastases: pathobiology and emerging targeted therapies Acta Neuropathol 123 2 2012 205 222
20. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 2 2011 134 141
21. R. Soffietti, R. Mueller, and U. Abacioglu Quality of life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases of solid tumors Neuro Oncol 12 Suppl. 4 2010 Ql-08
22. B.J. Slotman, M.E. Mauer, and A. Bottomley Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups J Clin Oncol 27 1 2009 78 84
23. B. Slotman, C. Faivre-Finn, and G. Kramer Prophylactic cranial irradiation in extensive small-cell lung cancer N Engl J Med 357 7 2007 664 672 (Pubitemid 47267236)
24. N.U. Lin, V. Dieras, and D. Paul Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer Clin Cancer Res 15 4 2009 1452 1459
25. E.L. Chang, J.S. Wefel, and K.R. Hess Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial Lancet Oncol 10 11 2009 1037 1044
26. M.E. Witgert, and C.A. Meyers Neurocognitive and quality of life measures in patients with metastatic brain disease Neurosurg Clin N Am 22 1 2011 79 85 vii
27. M.J.B. Taphoorn, and M. Klein Cognitive deficits in adult patients with brain tumours Lancet Neurol 3 3 2004 159 168 (Pubitemid 38229950)
28. A.J. Mitchell, S. Kemp, J. Benito-Leon, and M. Reuber The influence of cognitive impairment on health-related quality of life in neurological disease Acta Neuropsychiatr 22 1 2010 2 13
29. C.A. Meyers, J.A. Smith, and A. Bezjak Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial J Clin Oncol 22 1 2004 157 165 (Pubitemid 41095128)
30. M.J. Taphoorn, E.M. Sizoo, and A. Bottomley Review on quality of life issues in patients with primary brain tumors Oncologist 15 6 2010 618 626
31. M.J. Taphoorn, M.J. van den Bent, and M.E. Mauer Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial J Clin Oncol 25 36 2007 5723 5730
32. M.J. Taphoorn, R. Stupp, and C. Coens Health-related quality of life in patients with glioblastoma: A randomised controlled trial Lancet Oncol 6 12 2005 937 944 (Pubitemid 41685226)
33. I. Bosma, J.C. Reijneveld, and L. Douw Health-related quality of life of long-term high-grade glioma survivors Neuro Oncol 11 1 2009 51 58
34. P.D. Brown, M.J. Maurer, and T.A. Rummans A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival Neurosurgery 57 3 2005 495 504 discussion 495-504
35. F. Keime-Guibert, O. Chinot, and L. Taillandier Radiotherapy for glioblastoma in the elderly N Engl J Med 356 15 2007 1527 1535 (Pubitemid 46588417)
36. J. Wong, A. Hird, A. Kirou-Mauro, J. Napolskikh, and E. Chow Quality of life in brain metastases radiation trials: A literature review Curr Oncol 15 5 2008 25 45
37. E.M. Sizoo, L. Braam, and T.J. Postma Symptoms and problems in the end-of-life phase of high-grade glioma patients Neuro Oncol 12 11 2010 1162 1166
38. M. Groenvold, M.A. Petersen, and N.K. Aaronson The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care Eur J Cancer 42 1 2006 55 64 (Pubitemid 41818953)
39. K.C. Sneeuw, N.K. Aaronson, and M.A. Sprangers Value of caregiver ratings in evaluating the quality of life of patients with cancer J Clin Oncol 15 3 1997 1206 1217 (Pubitemid 27106309)
40. J.M. Giesinger, M. Golser, and A. Erharter Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual Life Outcomes 7 2009 87
41. P.D. Brown, P.A. Decker, and T.A. Rummans A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life Am J Clin Oncol 31 2 2008 163 168 (Pubitemid 351519168)
42. P.S. Steeg, K.A. Camphausen, and Q.R. Smith Brain metastases as preventive and therapeutic targets Nat Rev Cancer 11 5 2011 352 363
43. Y. Kienast, L. Von Baumgarten, and M. Fuhrmann Real-time imaging reveals the single steps of brain metastasis formation Nat Med 16 1 2010 116 122
44. F. Winkler, S.V. Kozin, and R.T. Tong Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases Cancer Cell 6 6 2004 553 563 (Pubitemid 40017699)
45. K.H. Plate, and H.D. Mennel Vascular morphology and angiogenesis in glial tumors ExpToxicolPathol 47 2-3 1995 89 94
46. I.J. Fidler, S. Yano, R.D. Zhang, T. Fujimaki, and C.D. Bucana The seed and soil hypothesis: vascularisation and brain metastases Lancet Oncol 3 1 2002 53 57 (Pubitemid 34121146)
47. R.K. Jain, T.E. Di, and D.G. Duda Angiogenesis in brain tumours Nat Rev Neurosci 8 8 2007 610 622 (Pubitemid 47093931)
48. W.M. Pardridge Drug and gene targeting to the brain with molecular Trojan horses Nat Rev Drug Discov 1 2 2002 131 139 (Pubitemid 41646520)
49. B. Slotman, C. Faivre-Finn, and G. Kramer Prophylactic cranial irradiation in extensive small-cell lung cancer N Engl J Med 357 7 2007 664 672 (Pubitemid 47267236)
50. C. Massard, J. Zonierek, and M. Gross-Goupil Incidence of brain metastases in renal cell carcinoma treated with sorafenib Ann Oncol 21 5 2010 1027 1031
51. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 3 1996 353 364 (Pubitemid 26272076)
52. Heon S, Yeap BY, Lindeman N, et al. The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations. Clin Cancer Res, 2012 (in press).
53. P.D. Bos, X.H. Zhang, and C. Nadal Genes that mediate breast cancer metastasis to the brain Nature 459 7249 2009 1005 1009
54. D.X. Nguyen, A.C. Chiang, and X.H. Zhang WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis Cell 138 1 2009 51 62
55. M.E. Hegi, A.C. Diserens, and P. Bady Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib - a phase II trial Mol Cancer Ther 10 6 2011 1102 1112
56. R. Soffietti, R. Mueller, and M. Abacioglu Quality of life results of an EORTC phase III randomized trial of adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors J Clin Oncol 28 Suppl. 2010 9036